Assessment of the Bioavailability of Iron in Iron Fortified Bouillon Cubes in Healthy Nigerian Women

NCT ID: NCT02815449

Last Updated: 2017-08-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-05-08

Study Completion Date

2017-07-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The prevalence of iron deficiency anemia is a wide spread problem in Africa and iron fortification can be an effective strategy to decrease this.

In the current study adding different levels of a stabilizer to iron fortified cubes and it's effect on iron bioavailability from these cubes will be studied in the context of a Nigerian meal in women.

24 Female subjects with low serum ferritin levels will be included in the study. The study will last 64 days and subjects will be asked to consume a breakfast and lunch prepared with a bouillon cube with isotope labeled iron during 3 periods of 5 consecutive days. The absorption of iron will be evaluated after every period and compared between the cubes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Iron Deficiency Anemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Low stabilizer level

Meals prepared with iron fortified cube with low stabilizer level

Group Type EXPERIMENTAL

Meals prepared with iron fortified cube with Low stabilizer level

Intervention Type OTHER

Meals prepared with iron fortified cube with Low stabilizer level

Medium stabilizer level

Meals prepared with iron fortified cube with medium stabilizer level

Group Type EXPERIMENTAL

Meals prepared with iron fortified cube with Medium stabilizer level

Intervention Type OTHER

Meals prepared with iron fortified cube with Medium stabilizer level

High stabilizer level

Meals prepared with iron fortified cube with high stabilizer level

Group Type EXPERIMENTAL

Meals prepared with iron fortified cube with High stabilizer level

Intervention Type OTHER

Meals prepared with iron fortified cube with High stabilizer level

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Meals prepared with iron fortified cube with Low stabilizer level

Meals prepared with iron fortified cube with Low stabilizer level

Intervention Type OTHER

Meals prepared with iron fortified cube with Medium stabilizer level

Meals prepared with iron fortified cube with Medium stabilizer level

Intervention Type OTHER

Meals prepared with iron fortified cube with High stabilizer level

Meals prepared with iron fortified cube with High stabilizer level

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy female Nigerian subjects;
* Age \> 18 and \<40 years at screening;
* Body weight \<65 kg;
* Apparently healthy: no medical conditions which might affect study measurements (judged by study physician);
* With iron deficiency judged by a serum ferritin concentration of \<15µg/L;
* Reported intense sporting activities ≤ 10h/w;
* Reported alcohol consumption ≤ 14 units/w;
* Willing and able to participate in the study;
* Having given a written informed consent.

Exclusion Criteria

* Being an employee of Unilever or the Department of Family, Nutrition and Consumer Science of the Obafemi Alowolo University;
* Blood donation or significant blood loss over the past 6 months;
* Being severely anemic (hemoglobin \< 8.0 g/dL)
* Reported use of any medically- or self-prescribed diet;
* Use of vitamin or mineral supplements and unwillingness to discontinue their use one week prior the study and during the study;
* Smoking or consuming tobacco in any form, and/or was smoking or consuming tobacco in any form for 6 months preceding the study and/or will be smoking or consuming tobacco in any form, during the study;
* Is pregnant or will be planning pregnancy during the study period;
* Is lactating or has been lactating in the 6 weeks before pre-study investigation and/or during the study period;
* Known gastrointestinal (including helminth infection) or metabolic disorders;
* Participation in another clinical trial during the last 30 days prior to the beginning of the study;
* Symptomatic malaria (no blood smear analyses on malaria required)
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Obafemi Awolowo University

OTHER

Sponsor Role collaborator

Unilever R&D

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Funke Olumakaiye, PhD

Role: PRINCIPAL_INVESTIGATOR

Obafemi Awolowo University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Obafemi Owalowo University

Ile-Ife, , Nigeria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Nigeria

References

Explore related publications, articles, or registry entries linked to this study.

Eilander A, Funke OM, Moretti D, Zimmermann MB, Owojuyigbe TO, Blonk C, Murray P, Duchateau GS. High Bioavailability from Ferric Pyrophosphate-Fortified Bouillon Cubes in Meals is Not Increased by Sodium Pyrophosphate: a Stable Iron Isotope Study in Young Nigerian Women. J Nutr. 2019 May 1;149(5):723-729. doi: 10.1093/jn/nxz003.

Reference Type DERIVED
PMID: 31004134 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FDS-SAV-2103

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Baby Iron Bioavailability Study
NCT03754543 COMPLETED NA
Iron & Alginate Study
NCT01528644 COMPLETED NA